| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.423 | 48.765 | 34.868 | 22.475 | 31.454 | 20.705 | 37.459 | 40.007 | 16.673 | 704 |
| Total Income - EUR | 43.312 | 49.233 | 35.027 | 22.791 | 31.527 | 20.705 | 37.459 | 40.044 | 16.992 | 704 |
| Total Expenses - EUR | 24.254 | 31.367 | 27.388 | 23.062 | 25.871 | 15.889 | 30.529 | 34.905 | 16.099 | 2.455 |
| Gross Profit/Loss - EUR | 19.059 | 17.866 | 7.639 | -271 | 5.656 | 4.816 | 6.930 | 5.140 | 893 | -1.751 |
| Net Profit/Loss - EUR | 17.759 | 17.247 | 7.286 | -499 | 5.341 | 4.610 | 6.556 | 4.739 | 796 | -1.751 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Ramoptik Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 597 | 591 | 581 | 570 | 559 | 548 | 536 | 538 | 4.822 | 3.709 |
| Current Assets | 10.132 | 14.924 | 14.950 | 17.175 | 16.137 | 21.112 | 30.055 | 36.633 | 45.390 | 26.790 |
| Inventories | 7.763 | 14.112 | 11.274 | 16.522 | 14.164 | 14.041 | 12.999 | 10.941 | 8.149 | 7.400 |
| Receivables | 237 | 635 | 3.357 | 570 | 1.661 | 6.677 | 16.811 | 25.068 | 31.758 | 13.932 |
| Cash | 2.132 | 177 | 318 | 83 | 312 | 394 | 245 | 624 | 5.483 | 5.458 |
| Shareholders Funds | -14.650 | 2.747 | 9.986 | 9.303 | 14.464 | 18.800 | 24.939 | 29.755 | 30.461 | 28.540 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.379 | 12.768 | 5.544 | 8.442 | 2.232 | 2.860 | 5.653 | 7.415 | 19.751 | 1.959 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Ramoptik Medical Srl